PAVM - PAVmed Inc.

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 47.06M
Enterprise value 50.05M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)65.16
Price/book (mrq)7.42
Enterprise value/revenue 78.94
Enterprise value/EBITDA -0.49

Trading information

Stock price history

Beta (5Y monthly) 0.85
52-week change 3-57.94%
S&P500 52-week change 32.72%
52-week high 32.3400
52-week low 30.3500
50-day moving average 30.4469
200-day moving average 30.6853

Share statistics

Avg vol (3-month) 3484.39k
Avg vol (10-day) 3705.81k
Shares outstanding 5104.53M
Implied shares outstanding 6N/A
Float 895.02M
% held by insiders 19.66%
% held by institutions 19.88%
Shares short (14 May 2023) 45.03M
Short ratio (14 May 2023) 49.7
Short % of float (14 May 2023) 45.16%
Short % of shares outstanding (14 May 2023) 44.81%
Shares short (prior month 13 Apr 2023) 45.47M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Mar 2023


Profit margin 0.00%
Operating margin (ttm)-14,462.62%

Management effectiveness

Return on assets (ttm)-76.61%
Return on equity (ttm)-280.18%

Income statement

Revenue (ttm)634k
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)136.00%
Gross profit (ttm)-3.24M
EBITDA -88.72M
Net income avi to common (ttm)-90.33M
Diluted EPS (ttm)-1.1100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)52.81M
Total cash per share (mrq)0.5
Total debt (mrq)49.5M
Total debt/equity (mrq)458.16
Current ratio (mrq)1.07
Book value per share (mrq)-0.25

Cash flow statement

Operating cash flow (ttm)-75.01M
Levered free cash flow (ttm)-46.48M